Amy P. Chiu
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity.
Journal: American journal of physiology. Heart and circulatory physiology
Published: October 08, 2017
Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling.
Journal: American journal of physiology. Heart and circulatory physiology
Published: September 29, 2016
High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature.
Journal: Cardiovascular research
Published: April 15, 2016
Cardiomyocyte-endothelial cell control of lipoprotein lipase.
Journal: Biochimica et biophysica acta
Published: February 02, 2016
Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: June 11, 2015
Endothelial cell heparanase taken up by cardiomyocytes regulates lipoprotein lipase transfer to the coronary lumen after diabetes.
Journal: Diabetes
Published: March 11, 2014
Hyperglycemia-induced secretion of endothelial heparanase stimulates a vascular endothelial growth factor autocrine network in cardiomyocytes that promotes recruitment of lipoprotein lipase.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 12, 2013
Endothelial heparanase regulates heart metabolism by stimulating lipoprotein lipase secretion from cardiomyocytes.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: March 09, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026